ArticleScientific reports2026
Progression-guided spatiotemporal memory transformers for accurate and consistent longitudinal brain tumor segmentation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For monitoring the progression of the disease and the efficacy of treatment, it is essential to segment the brain tumor. The majority of the available deep learning models in use today are based on discrete time points without considering the continuity of the process, which causes irregular shapes of the tumors in the subsequent images. In this study, a model called Progression-Guided Spatiotemporal Memory Transformer (PGSMT) has been proposed, which has a unique design to overcome the constraints. A progression-aware temporal memory module, where the latent tumor representation is built up across successive MRI scans, a cross-time structural alignment mechanism, where the consistency of tumor morphology is preserved with the ability to accommodate pathological changes, and a boundary-enhanced transformer encoder, where the spatial dependencies are captured and stored for precise boundary delineation, are the three major components of the proposed framework. PGSMT learns the temporal weighting, making it possible for the network to distinguish between noise and actual progression, unlike other temporal fusion methods. When compared with the Convolutional Neural Network (CNN), hybrid CNN-Transformer, and Transformer models, the proposed PGSMT outperforms these models in the BraTS longitudinal benchmark dataset. PGSMT shows statistically significant improvements (p < 0.05), with 88.1% Dice for the enhancing tumor, 90.2% Dice for the tumor core, and 93.0% Dice for the total tumor. while reducing inter-scan volumetric inconsistencies significantly. The relevant therapeutic interest in the dynamics of changing tumor volumes is substantiated by attention analysis. With respect to the empirical evaluation on the BraTS longitudinal data set, the results achieve 88.1% Dice for the enhancing tumor, 90.2% Dice for the tumor core, and 93.0% Dice for the total tumor, demonstrating statistically significant improvements (p < 0.05) compared to traditional methods, while the results indicate increased stability in terms of temporal variance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.